“…Although aglycone isoflavones in total SIF have lower amounts, they have higher biological activity in the intestine than that of their glycosidic isoflavones (Izumi, Piskula, Osawa, Obata, & Tob, 2000). Therefore, SIF must be transformed to be absorbed or utilized bioactive compounds by acid hydrolysis (Nemitz et al, 2017;Seo et al, 2017), enzyme treatment (Ahn-Jarvis, Teegarden, Schwartz, Lee, & Vodovotz, 2017), or microbial fermentation (Gaya, Peirotén, Álvarez, Medina, & Landete, 2018), because it cannot be synthesized in human body. However, acid hydrolysis methods have many disadvantages including low yields, acute reaction conditions and being harmful to human health, thus, cannot be used in large-scale applications.…”